Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Neil Woodford’s star slightly tarnished after Woodford Patient Capital Trust relegated from FTSE 250

The fund, which listed in April 2015 after an offering of 800mln shares at 100p each has dropped below that level over the past year reflecting disappointing performances from some of its portfolio
Neil Woodford
Woodford Patient Capital Trust shares were changing hands at 74p each in late afternoon trading, rallying 0.8% higher

Fund manager Neil Woodford saw his star status slightly tarnished on Wednesday following news his listed vehicle Woodford Patient Capital Trust PLC (LON:WPCT) will be relegated from the FTSE 250 after yesterday’s quarterly index reshuffle.

The fund, which listed in April 2015 after an offering of 800mln shares at 100p each which raised £800mln - the largest ever launch for a UK investment company.- has dropped below that level over the past year reflecting disappointing performances from some of its portfolio.

READ: Allied Minds and Circassia drag on value of Neil Woodford's investment portfolio

Woodford Patient Capital Trust shares were changing hands at 74p each in late afternoon trading, rallying 0.8% higher from the previous session’s close, and a 12% discount to the estimated net asset share price of 83p.

Lee Wild, Head of Equity Strategy at interactive investor said: “The demotion of Woodford Patient Capital trust from the FTSE 250 is no shock after a truly awful run of results from the manager's portfolio picks.

“The trust is down over 38% from peak to trough, and buying even at these low levels requires a leap of faith.”

The trust was launched by the renowned former Invesco Perpetual fund manager who left the company to create his own fund house in 2014.

An interesting time to invest

However, Charles Stanley Direct’s Rob Morgan suggests the relegation may mark an interesting time to invest.

He said: “The venture capital approach of this Trust is an interesting way to access innovative earlier-stage businesses. 

“The closed-ended nature of an investment trust offers liquidity, making it easier to buy and sell your investment – something it is difficult to do if you invest direct in early stage companies. However, these types of investments mean a very high level of risk and results will often take time.”

Morgan explained: “ When the Trust was launched there was a great deal of investor excitement but it has been a rocky road since then.”

He added: “There are some FTSE tracker funds that own the Trust that will be forced to sell when it is no longer a constituent of the index, though many such index funds tend to exclude investment trusts, and it is likely that all of this could add to depressed investor sentiment.

“However, the relegation could prove a good entry point for those that believe Mr Woodford’s assertion that the Trust has stakes in several companies that could be worth billions of dollars each in the future.”

The indexes reshuffle was calculated using closing prices on 29 May, and will come into effect on 18 June.

View full WPCT profile View Profile

Woodford Investment Management Timeline

Related Articles

cash
March 13 2018
RM Secured Direct Lending said it continues to see a "number of bespoke, higher-yielding lending opportunities to established businesses that offer attractive returns"
different currencies
January 11 2018
The decision to complement its retail offering with a corporate service is quite literally paying off
wedding bands in gold
September 06 2017
Coinsilium's Terrastream platform could reshape the landscape of junior mining funding

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use